International Cancer Research Partnership

Testimonials

How ICRP can help your organization realize its goals

Our partners know that if we are to conquer cancer, we need to work together as funding organizations. Our mission is to use the power of partnership to maximize public and non-profit investment in cancer research for the benefit of patients. “If you want to go quickly, go alone. If you want to go far, go together.”

Remember hearing @CancerAustralia present their collaborative funding scheme at the 2018 @icrpartners1 meeting in Washington and chatting about it with Paul Jackson afterwards. Fast forward to 2021 and very proud to have partnered and be funding #CancerResearch together

@DrHelenRippon (Worldwide Cancer Research, via Twitter)

body

Name

This test the MP4 upload

MP4 upload for testimonials feature

Body

Name

A global view of research gaps and opportunities - watch the video to hear our partners describe why ICRP is important to them!

ICRP Annual Meeting Delegates

ICRP is a collaborative international network for cancer research organizations - watch the video to find out more about the benefits of collaboration.

ICRP Annual Meeting Delegates

Body sample

Source Name

Body sample

PNG Upload

"ICRP is a great opportunity to meet with other funding organizations and develop important partnerships to progress cancer research. After conversations that began at an ICRP meeting, Susan G. Komen®, the world’s leading breast cancer organization, has announced a new partnership with Cancer Australia to co-fund research on metastatic breast cancer. The Komen – Cancer Australia Partnership will provide $450,000 over three years to fund the research of Dr Delphine Merino at La Trobe University in Australia. Through this partnership, cutting-edge technology will be used to identify genes that help breast cancer cells spread to distant organs and resist the effects of standard therapies. The ultimate goal of Dr. Merino’s research is to find the “Achilles heel” of metastatic breast cancer so that this devastating disease can be better treated and eliminated."

Read more about this initiative here

Dr Stephanie Reffey, Senior Director of Data science and Impact, Susan G. Komen & Dr Paul Jackson, General Manager Knowledge Management, Cancer Australia

This is sample test for the body

PNG Upload 2

Image Testimonial

Test Image

Test Media Deletion

Example

Testing the testimonials

Testimonials test

Body sample 3

Name

Body test

Sample test

ICRP offers a space for international cancer research organizations to share best practice.

ICRP Annual Meeting Delegates

ICRP organizations work together to identify opportunities for collaboration and address gap areas in research.

ICRP Annual Meeting Delegates

Why join ICRP? Watch the video to hear more from our partners about the benefits of membership....

Interested in finding out more? Contact operations@icrpartnership.org

ICRP Annual Meeting Delegates

body sample 2

PNG Upload

“Analysis of the national portfolio using the ICRP’s CSO coding system highlighted low investment in prevention research in the UK in 2004. As a result of the analysis, UK health research funders collaborated to fund over £34m and over 70 projects in prevention research to boost research capacity in this area.”

UK National Cancer Research Institute

Test Image

“ICRP’s Environmental Influences on Breast Cancer report highlighted that investment in this area was declining. Over the time period studied, the numbers of active awards declined and funding levels also fell, both in absolute terms, and as a percentage of the overall breast cancer portfolio. Using these data, and other evidence, CBCRP was able to promote additional research and capacity building in this area.”

Dr Mhel Kavanaugh-Lynch, California Breast Cancer Research Program

Test Text

PNG Upload

Body sample 2

Source

“Less than an hour since arriving at #ICRP2018 annual meeting and have already had a breakfast convo about a potential international collaboration. Living the @icrpartners1 mission!”

@DrHelenRippon (Worldwide Cancer Research)

“ICRP worked with the Metastatic Breast Cancer Alliance to provide data for a landscape analysis of metastatic breast cancer research, helping the Alliance realize it’s vision of improving outcomes for women with metastatic breast cancer”

Dr Marc Hurlbert, Metastatic Breast Cancer Alliance

Video Testimonial

Test Video

Test Image

Moon Moon

Single-funder organizations
Partner	Caveat
ACS	Dollar amounts found in the ICRP database are different than what is reported in the American Cancer Society's Annual Report. The dollar amounts spent on research reported in audited reports include operating expenses of the Research Department. Additionally, the dollar amounts also exclude all grants that were cancelled after being awarded, but include money that was returned from grants cancelled in the current year that were awarded in previous years. The dollar amounts reported in the database are unaudited and include grants awarded each fiscal year, exclusive of grants that cancelled before activation.
CBCRP	The California Breast Cancer Research Program grants are awarded only to individuals or institutions in California. Grants to the University of California receive only direct funds, while grants to other institutions also receive indirect costs (overhead) at 25% or the federally negotiated rate. Collaborative awards are counted in graphs and tables by the number of co-Principal Investigators rather than the number of projects.
Komen	Dollar amounts found in the ICRP database are different than what is reported on Komen\'s website or in Komen\'s Annual Report for the following reasons: Komen commits all funds necessary to support a research grant in the year it is awarded. Therefore, Komen\'s website reports on the full amount of each grant in the year it is initiated, while the ICRP data is annualized, as described. Komen funds research grants to our Scientific Advisors (Scientific Advisory Board members and Komen Scholars) and also provides discretionary funding of research-related projects that are not traditional research grants (e.g. support of the Komen Tissue Bank, ASCO and AACR meeting support). These are included in the overall Research Program spending, as reported in our Annual Report and on our website, but are not included in the ICRP database.
NIH	NIH projects in NIH Reporter assigned to the Spend Category ‘cancer’ are included in the ICRP database from FY2005 onwards. A small number of projects are excluded if essential information is missing (primarily Project title, Institution). Previous years’ data were drawn from the NFRP and may be incomplete. Starting in FY2007 NCI reports funding supplements, etc., for each grant separately instead of including them in the main project, therefore the number of projects may differ significantly from those of previous years. Projects with a cost of $0 include those that were a no-cost extension of the grant or when funding was provided by another NIH institute or center for that FY. NCI dollars in the ICRP database are drawn from NIH reporter and may not match dollars from other NCI-only databases.
Worldwide Cancer Research	Worldwide Cancer Research is unique in that the majority of our funding is awarded to researchers in countries outside the UK. Like many UK research charities, Worldwide Cancer Research only funds the direct costs of research. This creates significant problems in making quantitative comparisons between our funding and that provided by some of the other agencies in the ICRP, which fund both the direct and indirect costs (often called overheads) of research.

UK Organizations that are part of NCRI
Partner	Caveat
NCRI (GENERIC)	NCRI submits data to ICRP on behalf of all UK NCRI members from its Cancer Research Database (CaRD). The database only includes entries where funding can be directly attributed to a set of clearly defined research objectives. This means that the CaRD only contains information on all direct research funding (project, programme, fellowship, unit and institute) financed by NCRI Member organizations, for which an abstract has been submitted and where the project is active in any given financial year (April - March). Examples of funding that are currently outside the scope of CaRD are infrastructure, meeting grants and research management support."
Breakthrough (UK)	The ICRP database includes all Breakthrough Breast Cancer\'s research spend reported through its Annual Reports & Accounts. There is some variance due to different reporting periods (1 April snapshot versus full financial year) meaning that some research spend that is already committed may not be included in the ICRP figures. Expenditure on non-research charitable activities and management support costs are excluded from the NCRI, and by extension, the ICRP dataset. For further information on Breakthrough\'s research please visit www.breakthroughresearch.org.uk or email research@breakthrough.org.uk
CR-UK (UK)	The ICRP database includes around 70% of Cancer Research UK\'s direct research spend per financial year as reported through its Annual Reports & Accounts. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on vital research services, technology transfer, meeting grants, research management support and infrastructure to support Cancer Research UK\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Department of Health (UK)	There will always be some variance between the figures available on ICRP and the figures reported publicly by DH. There are two reasons for this. Firstly, there is variance due to different reporting periods (1 April snapshot of ICRP versus full financial year reporting by DH). Secondly, the Department\'s National Institute for Health Research (NIHR) encompasses various expenditure on NHS infrastructure for research relevant to cancer that is not in a format that it is possible to capture for ICRP.
Macmillan (UK)	The ICRP database represents about 90% of Macmillan Cancer Support\'s direct research spend per financial year. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on research management support and infrastructure to support Macmillan Cancer Support\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Scottish Government Health Directorates (UK)	Scottish Government is committed to improve the health of the Scottish population and the Chief Scientist\'s Office (CSO) funds across a broad range of relevant disease areas. Overall, 75% of the CSO spend is committed to research infrastructure in NHS Scotland. This and much other research expenditure is therefore outside the NCRI remit and, by extension, the ICRP dataset.

Canadian organizations who are part of the CCRA
Partner	Caveat
CCRA	Caveats/limitations specific to Canadian Cancer Research Alliance organizations can be accessed here.

Difference	Detail	Impact on investment figures
Not all CCRS participating organizations are included in the ICRP.	For the period 2005–2019, CCRA submitted data to the ICRP for 39 organizations and three now defunct multi-funded initiatives (CBCRA, CPCRI, and CTCRI). Note that the Canadian Breast Cancer Research Foundation merged operations with the Canadian Cancer Society in February 2017 and Prostate Cancer Canada merged in 2020. Projects within the CCRS total 27,239, of which 22,223 were reported to ICRP.	Medium
Not all CCRS projects are included in the ICRP.	“Related support” grants (i.e., travel awards, workshops/symposia, LOIs, etc.) are not submitted to ICRP, but are included in reports released by CCRA. In addition, equipment/infrastructure grants through the Canada Foundation for Innovation and for other funders where the cancer relevance weighting is less than 80% are not reported to the ICRP, but are included in CCRA reports. Any project with cancer relevance of less than 20% is also not reported to the ICRP.	Medium
Co-funded projects are listed by the administering organization.	Projects that are co-funded appear under the administering organization and are not duplicated per funder. Within CCRA reports, however, investments are reported by the actual funders.	Minor
ICRP uses a different approach to calculating annual project investment.	CCRA provides ICRP with the project budget (adjusted for cancer relevance) and start and end dates. A pro-rated calculation is used to derive annual investment. Within the CCRS, prorated calculations on the basis of annual project amounts (where those data are available) are used to calculate the annual investment.	Minor
ICRP uses different site coding conventions.	The cancer site/type codes used within the CCRS are different from ICRP site codes so results by site will vary in some instances.	Minor
ICRP has technical limitations.	ICRP has a technical limit of 12 site codes and 8 CSO codes and this requires truncation for a couple of large-scale projects within the CCRS.	Very minor
CCRA provides less descriptive information about its projects to ICRP.	Lay abstracts are submitted by CCRA to the ICRP in lieu of technical abstracts and in their language of origin. For projects without lay abstracts (and there are a significant number of these), only titles are provided. An English translation is provided alongside all French project titles to facilitate use of the search engine.	No impact on investment figures, but limits full functionality of search engine especially for organizations that do not collect/report lay abstracts.